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To elucidate cancer pathogenesis and its mechanisms at the molecular level, the collecting
and characterization of large individual patient tissue cohorts are required. Since most
pathology institutes routinely preserve biopsy tissues by standardized methods of formalin
fixation and paraffin embedment, these archived FFPE tissues are important collections of
pathology material that include patient metadata, such as medical history and treatments.
FFPE blocks can be stored under ambient conditions for decades, while retaining cellular
morphology, due to modifications induced by formalin. However, the effect of long-term
storage, at resource-limited institutions in developing countries, on extractable protein
quantity/quality has not yet been investigated. In addition, the optimal sample preparation
techniques required for accurate and reproducible results from label-free LC-MS/MS
analysis across block ages remains unclear. This study investigated protein extraction
efficiency of 1, 5, and 10-year old human colorectal carcinoma resection tissue and
assessed three different gel-free protein purification methods for label-free LC-MS/MS
analysis. A sample size of n  17 patients per experimental group (with experiment power 
0.7 and α  0.05, resulting in 70% confidence level) was selected. Data were evaluated in
terms of protein concentration extracted, peptide/protein identifications, method
reproducibility and efficiency, sample proteome integrity (due to storage time), as well
as protein/peptide distribution according to biological processes, cellular components,
and physicochemical properties. Data are available via ProteomeXchange with identifier
PXD017198. The results indicate that the amount of protein extracted is significantly
dependent on block age (p < 0.0001), with older blocks yielding less protein than newer
blocks. Detergent removal plates were the most efficient and overall reproducible protein
purification method with regard to number of peptide and protein identifications, followed
by the MagReSyn
®
SP3/HILIC method (with on-bead enzymatic digestion), and lastly the
acetone precipitation and formic acid resolubilization method. Overall, the results indicate
that long-term storage of FFPE tissues (as measured by methionine oxidation) does not
considerably interfere with retrospective proteomic analysis (p > 0.1). Block age mainly
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affects initial protein extraction yields and does not extensively impact on subsequent
label-free LC-MS/MS analysis results.
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INTRODUCTION
Tissues from biopsies, resections and/or surgery are routinely
taken from patients as a treatment option and/or to facilitate
more accurate diagnosis. The current universal tissue
preservation method of choice is formalin-fixation and
paraffin-embedment, to avoid tissue auto-proteolysis and
putrefaction, and to allow tissue specimens to be analyzed and
examined at a later stage [1–4]. Formalin-fixation is also
considered to be a superior preservative, since formaldehyde
quickly and easily penetrates and fixes tissues because of its
small molecular size, it causes minimal tissue shrinkage and
distortion, and produces exceptional staining results in
histopathology [4–6]. The formalin-fixed, paraffin-embedded
(FFPE) method of tissue preservation also allows for the
indefinite room temperature storage of FFPE blocks, thereby
removing much of the cost and difficulty associated with
fresh-cryopreserved tissue storage. The technique involves the
immersion and incubation of tissues in formaldehyde solution,
which is then replaced with alcohol (ethanol) in a dehydration
step. Dehydration of the sample is achieved by removing all the
water from the sample via ethanol incubation and subsequent
alcohol clearing with xylene incubation. The xylene is then
replaced by molten paraffin, which infiltrates the sample. The
final step involves paraffin-embedding and hardening of the
sample, which involves embedment of the specimen into
liquid embedding material such as wax. Samples are then
stored and archived for future use [1, 3, 4].
The protein profiling of FFPE tissues has immense potential
for biomarker discovery and validation. Tumor tissue represents
the ideal biological material for cancer proteomics studies and
biomarker discovery, since tumor-specific protein markers are
typically present at elevated concentrations in patient biopsy
tissue [4, 7]. Pathology institutes routinely process and store
patient biopsy and/or surgery tissue samples and therefore most
pathology archives consist of thousands of FFPE blocks, which
often comprise recent as well as decade-old blocks. These
repositories contain numerous varieties of patient tissue
specimens, including rare malignancies together with metadata
such as patient medical records, which contain information about
diagnosis, survival, and response to therapy. Due to this and the
fact that FFPE samples are easily stored and obtainable, many
recent proteomics, genomics and immunohistochemical studies
have focused on improving methods for analysis of FFPE tissue
[4, 8, 9]. However, the effect of long-term storage, at resource-
limited institutions in developing countries, on extractable
protein quantity/quality has not yet been investigated. In
addition, the optimal sample preparation techniques required
for accurate, reproducible results from label-free LC-MS/MS
analysis across block ages remains unclear.
[10] found no significant difference in protein identifications
from FFPE kidney tissue (normal and tumor) samples that were
stored up to 10 years. In addition, some top-down proteomic
studies have found no significant difference in protein yields
between younger and older FFPE blocks [11], whereas others
have found a significant decrease in protein yield as block age
increases [12, 13]. The main detrimental pre-analytical factor
appears to be tissue fixation time, with longer periods (>24 h)
leading to significant decreases in protein yield and number of
proteins identified via LC-MS/MS [13–15]. During the
completion of this study [16], published their work in which
they used tandem mass tag labeling and high pH fractionation to
evaluate the impact of storage time on FFPE ovarian
adenocarcinoma specimens (as old as 32 years) and found an
overall decline in identifiable peptides and phosphopeptides due
to the formalin fixation process but no further decline/
degradation due to storage duration. Even though the
aforementioned studies focused on storage duration/block age,
to our knowledge there is no evidence to demonstrate the
outcome of different protein purification techniques on older
samples. There remains a need to provide empirical evidence for
the impact of storage duration and conditions within the context
of a resource-limited environment, such as the Anatomical
Pathology department at Tygerberg Hospital (Western Cape,
South Africa).
Due to formalin-induced protein cross-linking, strong
detergents such as sodium dodecyl sulfate (SDS) are required
for total tissue solubilization and protein extraction from FFPE
tissues [17–19]. However, SDS binds to amino acids and thereby
changes the protein spatial conformational structure. This, in
turn, inhibits proteases, such as trypsin, from accessing protein
cleavage sites (which have become distorted through SDS
binding) and also inhibits protease activity by changing
enzyme conformational structure (through SDS binding). In
addition, SDS alters the chromatographic separation of peptides
and also interferes with electrospray ionization (ESI) mass
spectrometry by dominating mass spectra and significantly
suppressing analyte ion signals since it is readily ionizable
and present in greater abundances than individual peptide
ions. For these reasons, SDS must be completely depleted
from a sample before enzymatic digestion and LC-ESI MS/
MS analysis [17–20]. However, SDS removal with minimal
sample loss is a challenging task and several gel-free
approaches have been proposed over the years. These
approaches include incorporating the use of detergent
removal plates (DRP), protein precipitation with organic
solvents, such as the acetone precipitation and formic acid
resolubilization (APFAR) method [18, 20, 21], and/or
methods using hydrophilic interaction liquid chromatography
(HILIC) and magnetic resin (such as the Single-Pot Solid-
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Phase-enhanced Sample Preparation (SP3) method) [22] in the
sample processing workflow prior to LC-MS/MS analysis.
One of the aims of this study was to methodically characterize the
effects of storage time (over 1, 5, and 10 years) on the quality of data
produced via label-free LC-MS/MS analysis of FFPE tissue blocks
from a resource-limited pathology archive, to dispel any notions that
these samples may be inferior for whatever reason so that they can be
utilized with confidence in any future studies. In addition, three
different gel-free protein purification methods (APFAR, DRP and
MagReSyn® SP3/HILIC) for label-free LC-MS/MS analysis were also
assessed across all block ages. These protein purificationmethodswere
published within the last 5 years, and their comparative analysis have
not been carried out to our knowledge and this study provides
experimental data for this assessment together with statistical
support. Furthermore, the best suited method for analyzing
archived colorectal carcinoma (CRC) FFPE tissue was determined
with regards to peptide and protein identifications, reproducibility,
digestion efficiency, and any method-based protein selection bias.
TABLE 1 | Information of the FFPE specimens selected for analysis.
Patient number Block age (years) Patient age (years) Gender Diagnosis Grade Stage Location
1 1 75 M Adenocarcinoma Low-grade IIA Left colon
2 1 81 M Adenocarcinoma Low-grade IIA Left colon
3 1 68 F Adenocarcinoma Low-grade IIA Left colon
4 1 42 M Adenocarcinoma Low-grade IVA Left colon
5 1 80 F Adenocarcinoma Low-grade I Left colon
6 1 79 M Adenocarcinoma Low-grade IIA Left colon
7 1 49 M Adenocarcinoma Low-grade IIA Left colon
8 1 40 F Adenocarcinoma Low-grade IIA Left colon
9 1 56 M Adenocarcinoma Low-grade IIA Left colon
10 1 79 F Adenocarcinoma Low-grade IIA Left colon
11 1 64 F Adenocarcinoma Low-grade IIA Left colon
12 1 53 M Adenocarcinoma Low-grade IIIB Left colon
13 1 78 M Adenocarcinoma Low-grade IIA Left colon
14 1 51 F Adenocarcinoma Low-grade IIIB Left colon
15 1 31 M Adenocarcinoma Low-grade IIIB Left colon
16 1 73 F Adenocarcinoma Low-grade IIIB Left colon
17 1 54 F Adenocarcinoma Low-grade IIIC Left colon
18 5 51 F Adenocarcinoma Low-grade IIA Left colon
19 5 56 F Adenocarcinoma Low-grade IIIB Left colon
20 5 86 M Adenocarcinoma Low-grade IIA Left colon
21 5 59 M Adenocarcinoma Low-grade IIC Left colon
22 5 67 M Adenocarcinoma Low-grade IIA Left colon
23 5 82 M Adenocarcinoma Low-grade IIA Left colon
24 5 49 F Adenocarcinoma Low-grade IIIB Left colon
25 5 54 M Adenocarcinoma Low-grade IIA Left colon
26 5 58 M Adenocarcinoma Low-grade IIC Left colon
27 5 44 F Adenocarcinoma Low-grade I Left colon
28 5 50 M Adenocarcinoma Low-grade IIA Left colon
29 5 74 F Adenocarcinoma Low-grade IIA Left colon
30 5 54 M Adenocarcinoma Low-grade IIA Left colon
31 5 47 F Adenocarcinoma Low-grade IIIA Left colon
32 5 55 M Adenocarcinoma Low-grade IIIB Left colon
33 5 83 M Adenocarcinoma Low-grade IIA Left colon
34 5 60 M Adenocarcinoma Low-grade IIA Left colon
35 10 69 M Adenocarcinoma Low-grade IIIB Left colon
36 10 47 F Adenocarcinoma Low-grade IIA Left colon
37 10 58 F Adenocarcinoma Low-grade IIA Left colon
38 10 83 M Adenocarcinoma Low-grade IIA Left colon
39 10 57 F Adenocarcinoma High-grade IIA Right colon
40 10 46 F Adenocarcinoma High-grade IIA Right colon
41 10 77 F Adenocarcinoma Low-grade IIA Left colon
42 10 63 F Adenocarcinoma Low-grade IIA Left colon
43 10 67 M Adenocarcinoma Low-grade IIIB Left colon
44 10 50 F Adenocarcinoma Low-grade IIA Left colon
45 10 42 M Adenocarcinoma Low-grade IIA Left colon
46 10 71 F Adenocarcinoma Low-grade IIA Left colon
47 10 70 M Adenocarcinoma Low-grade IIA Left colon
48 10 69 M Adenocarcinoma Low-grade IIA Left colon
49 10 62 F Adenocarcinoma Low-grade IIA Right colon
50 10 78 M Adenocarcinoma Low-grade IIIB Left colon
51 10 33 M Adenocarcinoma Low-grade IIA Left colon
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MATERIALS AND METHODS
FFPE Human Colorectal Carcinoma
Resection Samples
FFPE tissue blocks, which consist of human CRC resection
samples, were obtained from the Anatomical Pathology
department at Tygerberg Hospital (Western Cape, South
Africa) after obtaining ethics approval from the Biomedical
Science Research Ethics Committee (BMREC) of the
University of the Western Cape, as well as the Health
Research Ethics Committee (HREC) of Stellenbosch
University. The FFPE blocks were anonymized prior to
processing. The 1-year-old blocks were archived since
approximately 2016 (when the tissue was resected), 5-year-old
blocks were archived since 2012, and 10-year-old blocks were
archived since 2007 (experiments/protein extractions were
performed in 2017/2018). Tissue processing and fixation
times/conditions and storage conditions are unknown, since
specimens were retrospectively collected. Seventeen patient
cases, per block age, were reviewed and selected (Table 1).
Using protein identification results from a pilot study
(unpublished results), an overall F-test for one-way ANOVA
determined that the sample size (n  17) per group/block age
resulted in a calculated power of 0.7 (α  0.05).
Patients diagnosed with colorectal adenocarcinoma, after
H&E staining, were reviewed by a pathologist to ensure tissue
quality and comparability (Figure 1). The selected slides had
carcinomas with more than 90% viable tumor nuclei.
Protein Extraction and Quantification
For each selected patient case (n  17 per experimental
condition), a number of 25 µm sections, which were equivalent
to 25 mm3 of manually micro-dissected FFPE tumor tissue per
sample, were cut and mounted onto generic glass microscopy
slides. Sections were air dried and processed for protein
extraction as is shown in Figure 2 (five batches of samples,
with randomized selection and inclusion of samples from each of
the different storage times, were processed for protein extraction.)
The method used for sample processing and protein extraction
was modified from the protocols used by [23, 24]. Briefly, tissue
sections (mounted on glass slides) were heated on a heating block
(65°C for 5 min), to melt the paraffin wax, followed by tissue
deparaffinization consisting of two consecutive incubations in
xylene (Sigma-Aldrich, United States) for 2.5 min and 1.5 min
each respectively, at room temperature. Tissue sections were then
rehydrated by successive incubations in absolute ethanol (Merck,
Germany), 70% (v/v) ethanol, and twice with distilled water, for
1 min each at room temperature. The tissues were collected in
protein LoBind microcentrifuge tubes (Eppendorf, Germany) by
scraping the tissue off the glass slides using a clean sterile scalpel
blade. Protein extraction buffer (50 mm Ammonium bicarbonate
(AmBic) (pH 8.0) (Sigma-Aldrich, United States), 2% (w/v) SDS
FIGURE 1 |Colonic adenocarcinoma resection tissue samples. Representative H&E stained sections of patient cases/block ages analyzed in this study. (A) 1-year-
old block. (B) 5-year-old block, and (C) 10-year-old block at ×100 magnification.
FIGURE 2 | Experimental design and workflow used to evaluate the
effects of block age and different sample processing methods. FFPE human
colorectal carcinoma resection tissues from 17 patients per block age (1, 5,
and 10-year old blocks) were cut and tumor areas were manually micro-
dissected for analysis. From each patient, tissue sections, which
corresponded to approximately 25 mm3 tissue per patient/sample, were cut
per sample. Protein was extracted and quantified, after which each patient
sample was split in three, for subsequent sample processing by either the
APFAR, DRP, or SP3/HILIC methods. Resultant peptides were analyzed via
LC-MS/MS and data analysis was performed on all sample MS/MS spectra.
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(Sigma-Aldrich, United States) was added to the samples at a
volume of approximately 20 µl protein extraction buffer per
mm3 of tissue (approximately 25 mm3 tissue per sample).
Samples were mixed by vortexing and incubated at 99°C in a
heating block with agitation set at 600 RPM for 1 h, after which
the samples were cooled/placed on ice before centrifugation at
16,000 x g and 18°C for 20 min to pellet the cell debris. The
clarified lysates of each sample was transferred to new protein
LoBind microcentrifuge tubes and an aliquot taken for protein
yield determination. All samples were stored at −80°C until
further processing. For protein yield determination, the total
protein extracted from the FFPE tissues were quantified using
the Pierce™ BCA Protein Assay Kit (Pierce Biotechnology,
Thermo Fisher Scientific, United States) according to
manufacturer’s instructions. The samples were subsequently
processed by the DRP, APFAR [18, 20, 21] and/or
MagReSyn® SP3/HILIC magnetic bead digestion method [25];
ReSyn Biosciences, South Africa), prior to LC-MS/MS analysis
(Figure 2).
Protein Purification Methods
Detergent Removal Plates Method
Detergent removal was carried out using detergent removal spin
plates (Pierce Biotechnology, Thermo Fisher Scientific,
United States) according to the manufacturer’s instructions.
Briefly, a detergent removal plate was placed on top of a wash
plate and the shipping solution spun out at 1,000 x g for 2 min.
The resin bed was equilibrated with 300 µl of 50 mm
Triethylammonium bicarbonate (TEAB) and spun through as
before, and this was repeated twice. Thereafter, 100 µg of protein
was loaded onto the columns and incubated at room temperature
for 2 min before spinning through at 1,000 x g for 2 min into the
sample collection plate. Samples were then transferred to protein
Lobind tubes and dried down by vacuum centrifugation. Once
dried, samples were resuspended in 30 µl of 50 mm TEAB.
Acetone Precipitation and Formic Acid
Resolubilization Method
A total of 100 µg protein was transferred to each protein Lobind
microcentrifuge tube and precipitated by addition of four
volumes of ice cold acetone (Sigma-Aldrich, United States)
followed by overnight incubation at −20°C. Samples were then
centrifuged at 21,000 x g for 15 min at 4°C. The supernatant was
discarded and the pellet washed with ice cold acetone. This
process was repeated for a total of three pelleting steps.
Thereafter, the pellets were air-dried and subsequently
solubilized by resuspension in 50 mm TEAB.
In-Solution Digestion
In-solution digestion was carried out on samples processed by the
APFAR and DRP methods. The protein was reduced by the
addition of 0.1 volumes of 100 mm tris(2-carboxyethyl)
phosphine (TCEP) (Sigma-Aldrich, United States) to each
sample followed by incubation at 60°C for 1 h. Alkylation was
accomplished by addition of 0.1 volumes of 100 mm methyl
methanethiosulphonate (MMTS) (Sigma-Aldrich,
United States), which was prepared in isopropanol (Sigma-
Aldrich, United States), to each sample and subsequent
incubation at room temperature for 15 min. Protein digestion
was accomplished by addition of 1:50 (trypsin: final protein ratio)
trypsin (Promega, United States) in a solution with 50 mmTEAB,
and overnight incubation at 37°C. Samples were dried down and
resuspended in 0.1% trifluoroacetic acid (TFA) (Sigma-Aldrich,
United States) prior to clean-up via Zip-Tip (Sigma-Aldrich,
United States), after which the samples were again dried down
and resuspended in a final volume of 12 µl liquid chromatography
(LC) loading buffer (0.1% formic acid (FA) (Sigma-Aldrich,




SP3/HILIC Method With On-Bead
Digestion
In preparation for the SP3/HILIC magnetic bead workflow,
MagReSyn® HILIC beads (ReSyn Biosciences, South Africa)
were aliquoted into a new tube and the shipping solution
removed. Beads were then washed with 250 µl wash buffer
(15% ACN, 100 mm Ammonium acetate (Sigma-Aldrich,
United States) pH 4.5) for 1 min then resuspended in loading
buffer (30% ACN, 200 mmAmmonium acetate, pH 4.5). The rest
of the process, described hereafter, was performed using a
Hamilton MassSTAR robotics liquid handler (Hamilton,
Switzerland). A total of 50 µg of protein from each sample was
transferred to a protein LoBind plate (Merck, Germany). Protein
was reduced with 10 mm TCEP (Sigma-Aldrich, United States)
and incubated at 60°C for 1 h. Samples were cooled to room
temperature and alkylated with 10 mm MMTS (Sigma-Aldrich,
United States) at room temperature for 15 min. MagReSyn®
HILIC magnetic beads were added at an equal volume to that
of the sample and a ratio of 5:1 total protein. The plate was
incubated at room temperature on a shaker at 900 RPM for
30 min for binding of protein to beads. After binding, the
beads were washed four times with 500 µl of 95% ACN for
1 min each. For digestion, trypsin (Promega, United States)
made up in 50 mm TEAB was added at a ratio of 1:10 total
protein, and the plate was incubated at 37°C on the shaker for 4 h.
After digestion, the supernatant containing the peptides was
removed and dried down. The samples were then resuspended
in LC loading buffer [0.1% FA (Sigma-Aldrich, United States), 2%
ACN (Burdick & Jackson, United States)].
Label–Free LC–MS/MS Analysis
LC-MS/MS analysis was conducted with a Q-Exactive
quadrupole-Orbitrap mass spectrometer (Thermo Fisher
Scientific, United States) coupled with a Dionex Ultimate
3,000 nano-UPLC system. All samples run by LC-MS/MS
were in a randomized order. Peptides were dissolved in a
solution of 0.1% FA and 2% ACN and loaded on a C18 trap
column (PepMap100, 300 µm × 5 mm × 5 µm). Samples were
trapped onto the column and washed for 3 min before the valve
was switched and peptides eluted onto the analytical column as
described hereafter. A gradient of increasing organic proportion
was used for peptide separation - chromatographic separation
was performed with a Waters nanoease (Zenfit) M/Z Peptide
CSH C18 column (75 µm × 25 cm × 1.7 µm) and the solvent
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system employed was solvent A [0.1% FA in LC water (Burdick
and Jackson, United States)] and solvent B (0.1% FA in ACN).
The multi-step gradient for peptide separation was generated at
300 nl/min as follows: time change 5 min, gradient change: 2–5%
solvent B, time change 40 min, gradient change 5–18% solvent B,
time change 10 min, gradient change 18–30% solvent B, time
change 2 min, gradient change 30–80% solvent B. The gradient
was then held at 80% solvent B for 10 min before returning it to
2% solvent B and conditioning the column for 15 min. All data
acquisition was obtained using Proxeon stainless steel emitters
(Thermo Fisher, United States). The mass spectrometer was
operated in positive ion mode with a capillary temperature of
320°C. The applied electrospray voltage was 1.95 kV. The mass
spectra were acquired in a data-dependent manner using
Xcalibur™ software version 4.2 (Thermo Fisher, United States)
(Details of data acquisition parameters are shown in
Supplementary Table S1).
Peptide and Protein Identification
Raw data containing centroid MS/MS spectra were converted
into mgf (Matrix Science, United Kingdom) files using
msconvert from the Proteo-Wizard software suite [12]. Peak
lists obtained from MS/MS spectra were identified using X!
Tandem (version X!Tandem Vengeance 2015.12.15.2) [26], MS
Amanda (version 2.0.0.9706) [27] and MS-GF+ (version
2018.04.09) [28]. The search was conducted using SearchGUI
(version 3.3.3) [29]. Protein identification was conducted
against a concatenated target/decoy [30] version of the Homo
sapiens (20,341, >99.9%) [with Sus scrofa (1, <0.1%)]
complement of the UniProtKB [31] human reviewed Swiss-
Prot proteome (one trypsin Sus scrofa sequence was also
obtained from UniProtKB), downloaded on May 21, 2018
(Supplementary Data Sheet S1). The decoy sequences were
created by reversing the target sequences in SearchGUI. The
identification settings were as follows: Trypsin, Specific, with a
maximum of 2 missed cleavages; 10.0 ppm as MS1 and 0.02 Da
as MS2 tolerances; fixed modifications: Methylthio of C
(+45.987,721 Da), variable modifications: Oxidation of M
(+15.994,915 Da), Deamidation of N and Q (+0.984,016 Da);
fixed modifications during refinement procedure: Methylthio of
C (+45.987,721 Da), variable modifications during refinement
procedure: Acetylation of protein N-term (+42.010565 Da),
Pyrolidone from E (--18.010565 Da), Pyrolidone from Q
(--17.026549 Da), Pyrolidone from carbamidomethylated C
(--17.026549 Da). All algorithms specific settings are listed in
the certificate of analysis available in Supplementary Data
Sheet S1. Peptides and proteins were inferred from the
spectrum identification results using PeptideShaker version
1.16.40 [32]. Peptide Spectrum Matches (PSMs), peptides and
proteins were validated at a 1% False Discovery Rate (FDR)
estimated using the decoy hit distribution (example of an
annotated MS/MS spectrum for a peptide is shown in
Supplementary Image S1). All validation thresholds are
listed in the certificate of analysis (Supplementary Data
Sheet S1). Post-translational modification localizations were
scored using the D-score [33] and the phosphoRS score [34]
with a threshold of 95.0 as implemented in the compomics-
utilities package [35] (example of post-translational
modification localizations for a peptide is shown in
Supplementary Image S2).
Data and Statistical Analyses
Qualitative and quantitative data were exported from
PeptideShaker and parsed using in-house scripts and graphs
generated in Jupyter lab (using Pandas, NumPy, and
Matplotlib Python packages), as well as Microsoft® Excel.
Additional statistical analyses were performed using SAS®
university edition and SAS® Studio version 3.8 (results of the
statistical tests that were performed are listed in Supplementary
Table S2). To determine if sample distributions were normal, a
Kolmogorov–Smirnov or Shapiro–Wilk test was performed, with
D denoting the test statistic for the Kolmogorov–Smirnov test
and W denoting the test statistic for the Shapiro–Wilk test. For
normal distributions, comparison of means across 3 (or more)
groups was performed using the parametric ANOVA procedure,
with F (F-ratio) denoting the test statistic. The Kruskal–Wallis
nonparametric test for medians was used when data were from a
non-normal distribution, and H denotes the test statistic. For all
statistical reporting, the test statistic value is given along with the
degrees of freedom (in brackets after the test statistic symbol) and
p-value. Post hoc statistical analyses were performed on
significant results using Bonferroni or Dunn’s test [36]; Elliott
and Hynan, 2011).
Spectrum counting abundance indexes were estimated using
the Normalized Spectrum Abundance Factor (NSAF) [37]
adapted for better handling of protein inference issues and
peptide detectability. The NSAF method followed here
involves counting the number of spectra attributed to each
protein in the result set, which is subsequently normalized to
a relative abundance [29, 37, 38]. In the PeptideShaker
implementation, this count is then normalized for the length
of the protein, the presence of shared peptides, as well as
redundant peptides [29, 38]. The spectrum counting indexes
were exported from PeptideShaker and parsed using in-house
scripts. The NSAF values were multiplied by the lowest factor
calculated for each pair of conditions compared, in order to deal
with integers and facilitate comparisons. These NSAF values were
then used to estimate the extent of differential protein abundance
by calculating the Pearson’s correlation coefficient (PCC), for
each pair of conditions compared, to assess the relationship/level
of correlation between samples. PCC graphs were generated in
Jupyter lab using Pandas, NumPy, and Matplotlib Python
packages. Principal component analysis (PCA) was performed
for each patient case/sample’s list of identified proteins and
corresponding NSAF values, with Jupyter lab, using Pandas,
NumPy, Scikit-learn, Seaborn and Matplotlib Python packages.
The physicochemical properties of the identified peptides,
including the hydropathicity (Kyte-Doolittle scale), molecular
weight, and isoelectric point were calculated for each sample
using the Protein property analysis software (ProPAS) version
1.1 [39].
Venny version 2.1.0 [40] was used to generate Venn diagrams
to visualize the consistency of peptide identifications between
samples.
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Protein annotations regarding subcellular localization were
retrieved from Ensembl1 using GOSlim UniProtKB-GOA2 to
minimize the number of terms retrieved. Hypergeometric
testing was used to calculate the significance of gene
ontology terms.
Inkscape Version 0.92.4 (5da689c313, 2019–01-14) (https://
www.inkscape.org) was used to combine multiple graphs into
single figures, add color and/or patterns and increase figure
resolution.
Data Sharing Information
The mass spectrometry proteomics data [41] have been deposited
to the ProteomeXchange Consortium [42] via the PRIDE [43]
partner repository with the dataset identifier PXD017198 and
DOI: 10.6019/PXD017198.
Default PeptideShaker protein reports for each sample and
quality controls are listed in Supplementary Tables S3–S5.
RESULTS AND DISCUSSION
The objectives of this study were to evaluate three different
sample processing methods (the APFAR or DRP methods
followed by in-solution digestion, or the SP3/HILIC method
with magnetic bead-based digestion) as well as the effect of
storage time (FFPE tissue block age) on protein extraction
efficiency and reproducibility. Subsequent proteomic analysis
by label-free LC-MS/MS evaluated the proteome coverage,
proportion of missed cleavages, and enrichment/selection bias
based on sample processing method used.
Protein Extraction and Quantification
The BCA total protein quantitation assay results of all samples
(after protein was extracted from approximately 25 mm3 patient
tumor tissue using 500 µl of protein extraction buffer per sample)
are shown in Figure 3.
A Kruskal–Wallis test was conducted to examine the
differences in protein yield between block ages
(Supplementary Table S2). Protein yield was significantly
affected by block age (H (2)  23.92, p < 0.0001), as seen in
Figure 3. Based on Dunn’s post hoc testing results, there is
evidence that the distribution of protein yields are significantly
different for 1-year-old blocks vs 10-year-old blocks and for 1-
year-old blocks vs 5-year-old blocks, but not for 5-year-old blocks
vs 10-year-old blocks (results and conclusions are shown in
Supplementary Table S2).
The 10-year-old FFPE tissues generated overall lower protein
yields (an average of 1.65 ± 0.04 mg/ml) compared to the 5-year-
old FFPE tissues, which generated an average of 2.46 ± 0.03 mg/
ml protein, and the 1-year-old FFPE tissues, which generated an
average of 3.82 ± 0.03 mg/ml protein. This corresponds to
approximately 825 μg, 1,230 μg, and 1910 µg protein extracted
from the 10, 5 and 1-year-old FFPE tissues, respectively, by using
approximately 25 mm3 tissue per sample [14]. were able to extract
300–400 µg (0.14 mg/ml) protein from 1.18 mm3 FFPE colon
adenoma tissue (of 60 µm thickness and 5 mm diameter), which
is approximately 4 times higher. However, they noted a
suppressive effect of formalin-fixation on protein yield
estimates, using the BCA assay. This effect occurs because the
amino acids that contribute to the reduction of copper are also
FIGURE 3 | BCA total protein quantitation assay results for the different block ages. Protein was extracted from approximately 25 mm3 patient tumor tissue using
500 µl protein extraction buffer per sample (n  17 patients per group, p < 0.0001). The blue bars indicate protein yield from 1-year-old FFPE blocks, the red bars indicate
protein yield from 5-year-old FFPE blocks, and the green bars indicate protein yield from 10-year-old FFPE blocks. The red dotted line indicates the average protein yield
obtained from the 10-year-old FFPE blocks, which is 1.65 mg/ml protein.
1www.ensembl.org
2www.ebi.ac.uk/GOA
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susceptible to reactions with formaldehyde. Therefore, they
empirically determined a correction factor for protein yield
estimates of FFPE tissues (using the BCA assay) by comparing
it to freshly frozen colon adenoma tissue replicates’ protein yields.
They then used this correction factor to measure the amount of
protein generated from their FFPE samples. Since we are not
comparing fresh tissues to FFPE tissues, we did not determine the
correction factor of our dataset and we report the protein yield
estimates only. In addition [44], also extracted higher protein
yields at 100 mg/ml protein from 0.1 mm3 FFPE colonic adenoma
tissue and [13] extracted 2.76 mg/ml protein from approximately
1-year-old and 1.48 mg/ml protein from approximately 21-year-
old (1.5 mm3) FFPE colon carcinoma tissue. On the other hand
[45], extracted less protein than reported here, with 250 µg
protein from approximately 18 mm3 FFPE colon carcinoma
tissues that were stored for less than 5 years. Therefore, the
amount of protein extracted here falls within the published
ranges for FFPE colon tissue.
Although approximately 25 mm3 of manually microdissected
tumor tissue per sample was used for protein extraction, and the
volume of protein extraction buffer kept constant at 500 µl per
sample, the total amount of extractable protein and protein yield
FIGURE 4 | Comparison of the number of peptides and proteins identified for the different protein purification methods for each block age. (A) Box and whiskers
plots of the number of peptides identified (for all 17 patient cases) per block age (p < 0.03 for 1 and 10-year-old blocks), and protein purification method (p  0.0125 for
DRP). (B) Box and whiskers plots of the number of proteins identified (for all 17 patient cases) per block age (p  0.0002 for 1-year-old blocks) and protein purification
method (p > 0.05 for all methods). Blue boxplots refer to APFAR samples; Red boxplots refer to DRP samples; Green boxplots refer to SP3/HILIC samples. For all
boxplots, 5-year-old samples are represented by dots; 10-year-old samples are represented by diagonal lines.
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TABLE 2 | Known proteins deregulated in colon cancer.




























O95994 AGR2 Anterior gradient protein 2
homologue
19.97 Downregulated in CRC [47] 88 100 94 94 100 94 100 94 100
Q13951 CBFB Core-binding factor subunit
beta





41.37 Upregulated in CRC [49] 0 0 6 0 0 0 0 0 0
P10645 CHGA Chromogranin-A 50.66 Downregulated in CRC [50] 29 29 18 18 18 18 24 18 18
A8K7I4 CLCA1 Calcium-activated chloride
channel regulator 1
100.16 Regulator of calcium channels, frequently
downregulated in CRC [51]
59 53 41 59 59 47 53 53 47
Q96KP4 CNDP2 Cytosolic non-specific
dipeptidase
52.84 Overexpressed in CRC [52] 82 88 94 100 88 100 94 94 100
P07148 FABP1 FABP1 protein 14.20 Downregulated in CRC [47] 100 100 71 94 100 88 94 100 88
Q9Y6R7 FCGBP IgGFc-binding protein 571.64 Downregulated in CRC [47] 76 94 82 76 94 76 82 88 82
P56470 LGALS4 Galectin-4 35.92 Downregulated in CRC [47] 100 100 100 100 100 100 94 100 100
P09429 HMGB1 High mobility group
protein B1
24.88 Overexpression in CRC correlates with poor
prognosis [53]
76 88 76 100 100 94 94 82 94
P01042 KNG1 Kininogen-1 71.91 Frequently overexpressed in CRC [54] 29 41 53 53 59 82 29 47 65
Q9UHB6 LIMA1 LIM domain and actin-binding
protein 1
85.17 Downregulated in CRC [47] 0 0 6 0 0 24 6 6 0
P15941 MUC-1 Mucin-1 122.03 Frequently overexpressed in CRC, marker of
poor prognosis [55]
0 6 12 6 6 12 0 6 6
Q02817 MUC-2 Mucin-2 539.96 Downregulation correlates with proliferation
markers and with poor prognosis [55, 56]
59 59 76 71 65 71 65 71 76
P06748 NPM1 Nucleophosmin 32.55 Protein involved in carcinogenesis,
overexpressed in CRC [57, 58]
100 100 100 100 100 100 100 100 100
Q6UX06 OLFM4 Olfactomedin-4 57.24 Protein overexpressed in CRC [54] 29 18 29 35 24 29 29 24 29
Q9Y617 PSAT1 Phosphoserine
aminotransferase
40.40 Upregulated in CRC [59] 0 0 6 18 12 12 18 12 18
P53992 Sec24C Protein transport protein
Sec24C
118.25 Overexpressed in early CRC stages, while
downregulated in advanced CRC stages [54]
0 0 0 0 6 6 6 0 0
P36952 SERPIN
B5
Serpin B5 42.07 Upregulated in CRC [60] 29 6 29 35 6 29 29 6 29



































still differed among the patient samples within the same block
ages (Figure 3). Similar variations in protein yields were also
observed by [13] and is also noted in FFPE protein extraction
protocols, such as the [46] manual, which explains that protein
yield obtained from FFPE protein lysates may vary between
samples due to variance in pre-analytical factors such as tissue
handling and inconsistencies/differences in the formalin-fixation
and paraffin-embedment protocol, which affects how well
proteins will be preserved. They recommend increasing the
amount of starting material/tissue if the quality of protein
preservation in the FFPE sample is questionable [46].
The Effect of Block Age and Protein
Purification Methods on Peptide and
Protein Identification
The efficiency and reproducibility for each protein purification
method, as well as the effect of storage time/block age, at both
peptide and protein level, was assessed with regards to proteome
coverage (number of peptides and proteins identified) (Figures
4A,B) and known protein biomarkers (proteins deregulated in
colon cancer) from the literature, which were also identified in the
data (Table 2).
Average results for all samples (Figure 4) show that, overall,
the DRP method performed the best with the highest overall
peptide and protein identifications, followed by the SP3/HILIC
method. The APFAR method generated the lowest numbers of
peptide and protein identifications (Results are shown in
Supplementary Table S6).
One-way ANOVA or Kruskal–Wallis tests were conducted
(results and conclusions are listed in Supplementary Table S2) to
determine if the number of identified peptides and proteins were
significantly different between block ages, as well as for each
protein purification method.
Statistical analyses comparing protein purification method
performance per block age indicated the following: For the 1-
year-old blocks, based on post hoc Bonferroni (Dunn) t tests, the
DRP method differs significantly (F (2)  12.78, p < 0.0001, α 
0.05) with regards to validated peptide identifications, however
there was no significant difference between the numbers of
validated peptides identified for the APFAR and SP3/HILIC
methods. Based on Dunn’s post hoc testing results, there is
also evidence that the distribution of validated protein
identifications (for 1-year old blocks) are significantly different
(p  0.0002) for DRP vs APFAR processing, but not for DRP vs
HILIC and APFAR vs HILIC protein purification methods. With
regards to validated peptide and protein identifications, there is
no significant difference (p > 0.05) between protein purification
methods for 5-year old blocks. For the 10-year old blocks, based
on post hoc Bonferroni (Dunn) t tests, the DRP and APFAR
methods differ significantly (F (2)  3.78, p  0.0299, α  0.05)
with regards to validated peptide identifications, however there is
no significant difference between the APFAR and SP3/HILIC and
the DRP and SP3/HILIC methods.
Statistical analyses comparing the differences between
block ages (effect of block age on the number of peptide/
protein identifications) within each protein purification
method indicated the following: Both the APFAR and SP3/
HILIC methods performed most consistently across block
ages, with no significant difference between 1, 5 and 10-year-
old blocks [APFAR method: F (2,48)  0.88, p  0.42 for
peptides identified and H (2)  2.28, p  0.32 for proteins
identified; SP3/HILIC method: F (2,48)  0.03, p  0.97 for
peptides identified and H (2)  0.101, p  0.95 for proteins
identified]. Only the DRP method showed a significant
difference between the block ages with regard to numbers
of peptides identified [F (2)  4.81, p  0.0125, α  0.05], with a
significant difference between 1 and 5-year-old blocks, as well
as 1 and 10-year-old blocks, but no significant difference
between 5 and 10-year-old blocks. In addition, no significant
difference was detected for the number of proteins identified
[F (2,48)  2.53, p  0.09].
The protein purification methods that did not show any
significant differences between block ages, are in accordance
with the findings of other studies [10, 14]. [14] also assessed
the effect of storage time/block age on FFPE colon adenoma tissue
samples (stored for 1, 3, 5, or 10 years), using isoelectric focusing
to fractionate peptides before LC-MS/MS analysis. They found no
significant difference between the numbers of proteins identified
for each block age and concluded that long-term storage of FFPE
colon adenoma tissues did not compromise the samples. In
general, the proteome coverage reported here (for all the block
ages and protein purification methods) falls within the range of
several other studies of proteomic analysis of FFPE tissue [3, 14,
62, 63], with higher identification numbers reported by other
studies [10, 44, 64, 65]. Table 2 shows known proteins that are
deregulated in colon cancer that were also identified in the data.
The % occurrence of these proteins within each group of 17
patients per experimental condition was calculated and shows
that there are no observable differences due to block age.
However, the DRP method shows overall higher % occurrence
of these protein biomarkers, compared to the other protein
purification methods.
The Effect of Block Age and Protein
Purification Methods on Peptide-Level
Reproducibility
The qualitative reproducibility for each sample and experimental
condition was also measured in terms of peptide identification
overlap (shown in Supplementary Image S3), calculated from
the peptide sequences identified in each sample and experimental
condition, irrespective of peptide abundance.
Supplementary Image S3A illustrates that the APFAR
method showed the highest peptide overlap/common peptides
(46.5%) between samples of different block ages. This was
followed by the SP3/HILIC method, with 45.4% peptide
overlap, and the lowest peptide overlap was seen for the DRP
method at 43%. Overall, there was no substantial difference
between uniquely identified peptides of the different block
ages (ranging from 11.3% to 13.2%) for the APFAR and SP3/
HILIC methods. However, the 1-year-old blocks processed with
the DRP method had the highest percentage of uniquely
identified peptides at 20.4%.
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The shared peptides for each protein purification method
within a specific block age are shown in Supplementary
Image S3B. The 10-year-old blocks showed the highest
peptide overlap/common peptides (37.5%) between the
different protein purification methods. This was followed by
the 5-year-old blocks, with 36.7% peptide overlap, and the
lowest peptide overlap was seen for the 1-year-old blocks at
33.3%. This could be due, in part, to similar proteins extracted
from the older blocks (since formaldehyde-induced cross-linking
continues with time), compared to more diverse sets of proteins
extracted from the more recently preserved 1-year-old blocks
[66]. Due to the continuation and extent of formaldehyde-
induced protein cross-linking with time, the extraction of full-
length proteins from older FFPE blocks is also more difficult [66].
In addition [67], were able to identify small proteins, without
antigen retrieval and enzymatic digestion steps, via mass
spectrometry imaging. They hypothesize that not all proteins,
especially small proteins (with short amino acid sequences and
low lysine content), react with formaldehyde to the same extent.
However, larger proteins (with longer amino acid sequences and
greater lysine content) were more challenging to detect via mass
spectrometry, and therefore have a greater probability of being
more extensively crosslinked by formaldehyde. On average, for all
block ages and protein purification methods, the identified
proteins were in the range of 40–60 kDa (data not shown).
This therefore indicates that mostly low and medium
molecular weight proteins were extracted from the FFPE
tissues at all block ages.
Supplementary Image S3C shows that, when all the identified
peptides for each block age is combined within a protein
purification method, there is 34.1% overlapping peptides
shared between the different methods. The DRP method had
the highest percentage of uniquely identified peptides at 19.5%,
followed by the SP3/HILIC method, with 15.8% unique peptides,
and the lowest uniquely identified peptides was seen for the
APFAR method at 9.9%.
Physicochemical Properties of Extracted
and Processed Peptides
The effect of archival time/block age as well as protein
purification method protein selection/enrichment bias was
assessed with regards to peptide sequence physicochemical
properties in Figure 5, which illustrates the peptide
distribution according to hydropathicity, molecular weight and
isoelectric point (pI). Kruskal–Wallis tests were conducted to
determine if there were significant differences between
experimental conditions (Supplementary Table S2).
Overall, a comparison of the majority (upper and lower
quartiles) of all peptides of all experimental conditions shows
that they share similar hydropathicity scales (Figure 5A). There is
a significant difference (p < 0.0001) between the hydropathicity of
peptides generated in all experimental conditions
(Supplementary Table S2), however, the average relative
hydropathicity of all the samples are negative (below zero),
which indicates that the majority of peptides that were
extracted and processed, by all three protein purification
methods and across all block ages are hydrophilic [36, 68].
Figure 5B indicates that the molecular weight ranges of
identified peptides are relatively constant across all samples
and experimental conditions, with the majority >1000 Da and
<2000 Da. There is a significant difference (p < 0.0001) between
the molecular weights of peptides generated via the different
protein purificationmethods for 1, 5 and 10-year old blocks.With
regards to block age differences, there is no significant difference
(p  0.26) between the molecular weights of peptides generated
via the DRPmethod, however there is a significant difference (p <
0.05) between the molecular weights of peptides generated using
the APFAR and/or SP3/HILIC methods.
FIGURE 5 | Physicochemical properties of identified peptides for all
experimental conditions (n  17 patients per group). (A) Hydropathicity based
on GRAVY scoringmatrix. (B)Molecular weight (MW). (C) Isoelectric point (pI).
Blue boxplots refer to APFAR samples; Red boxplots refer to DRP
samples; Green boxplots refer to HILIC samples. For all boxplots, 5-year-old
samples are represented by dots; 10-year-old samples are represented by
diagonal lines.
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There is a significant difference (p < 0.0001) between the pI
ranges of peptides generated in all experimental conditions,
however, the pI range values are relatively similar across all
samples and experimental conditions, with the majority above
pI 4 and below pI 7 (Figure 5C).
These results are in accordance with previous studies that used
the APFAR and SP3/HILIC methods [20–22, 69].
The Effect of Block Age and Protein
Purification Methods on Protein-Level
Reproducibility
The quantitative reproducibility between experimental
conditions were expressed as PCC dot plots (Figure 6), which
were calculated based on the NSAF abundance values for
identified proteins in each sample and experimental condition.
PCA plots were also generated from this data to assess the
variance between block ages and the protein purification
methods (Figure 7).
Figure 6 shows the correlation of protein abundance for all
protein purification methods for each block age. This illustrates
that, for 1-year-old blocks, the DRP and SP3/HILIC methods
yielded comparable relative protein abundances (PCC value of
0.863), whereas proteome composition correlation was lower for
the AFFAR and DRP (PCC value of 0.755) as well as APFAR and
SP3/HILIC (PCC value of 0.789) methods. Overall, the 5 and 10-
year-old blocks show similar proteome composition correlation
between the protein purification methods.
For 5-year-old blocks, the PCC values for the APFAR and SP3/
HILIC, as well as DRP and SP3/HILIC methods are
approximately equal, 0.838 and 0.839, respectively. The
APFAR and DRP method has a higher PCC value of 0.859,
indicating slightly higher correlation in proteome composition
between these two protein purification methods.
FIGURE 6 | Correlation of protein abundance between all protein purification methods for each patient sample. (A) Correlation of protein abundance for all protein
purification methods for 1-year-old blocks/samples (n  17 patients per group). (B) Correlation of protein abundance for all protein purification methods for 5-year-old
blocks/samples (n  17 patients per group). (C) Correlation of protein abundance for all protein purification methods for 10-year-old blocks/samples (n  17 patients per
group). The Pearson correlation coefficients (r2) are indicated on each plot and plot axes values are the normalized NSAF values for proteins present in both
condition compared per plot.
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For 10-year-old blocks, the PCC values for the APFAR and
DRP as well as DRP and SP3/HILIC methods were the same. The
APFAR and SP3/HILIC method has a lower PCC value of 0.804,
indicating slightly lower correlation in proteome composition
between these two protein purification methods. These results
indicate that sample processing with the different methods
introduces an observable bias with regard to proteome
composition. This bias is also more pronounced for 1-year-old
blocks, compared to older blocks.
PCA plots showing clusters of samples, based on their
similarities, were generated for all block ages and protein
purification methods (Figure 7). The samples that have
similar expression profiles are clustered together. Figures
7A–C show the clustering of different block ages (1, 5, and
10 years) for each protein purification method, with the DRP
method having the lowest variance (10.73%) between block ages,
followed by the SP3/HILIC method (13.68%), and the APFAR
method, which has the highest variance at 14.57%.
For the protein purification methods (Figures 7D–F), the 10-
year-old blocks/samples shows the lowest variance between the
different methods (11.4%), followed by the 5-year-old blocks/
samples. This could be due, in part, to similar proteins extracted
from the older blocks because the formaldehyde-induced protein
cross-linking process is continual and becomes more extensive
with time [66] (also noted and discussed in The Effect of Block Age
and Protein Purification Methods on Peptide-Level
Reproducibility). The 1-year-old blocks/samples (Figure 7D)
shows the highest variance (15.86%) between the different
methods.
GO Analysis of Identified Proteins
The effect of storage time/block age as well as the protein
purification methods’ protein selection biases were assessed
with regards to the main biological processes and cellular
components present within the identified proteins, using Gene
Ontology (GO) annotation. The distribution of the percentages of
proteins belonging to each GO term was plotted for GO terms
that occurred at >15% frequency for all samples and experimental
conditions (Figure 8).
Overall, similar GO profiles were obtained for all samples,
therefore only the GO terms that showed some observable
difference between experimental conditions were plotted.
Figure 8A shows the percentage frequency at which the
identified proteins (of all experimental conditions) occurs for
FIGURE 7 | PCA plots for all block ages and protein purification methods. The NSAF values for proteins identified from each patient case were normalized and
dimensionality reduced by principal component analysis of the datasets. (A) PCA plot of all block age (1-year-old  red; 5-year-old  green; 10-year-old  blue) samples
processed via the APFAR method. (B) PCA plot of all block age (1-year-old  red; 5-year-old  green; 10-year-old  blue) samples processed via the DRP method. (C)
PCA plot of all block age (1-year-old  red; 5-year-old  green; 10-year-old  blue) samples processed via the HILICmethod. (D) PCA plot of 1-year-old samples for
all protein purification methods (APFAR  red; DRP  green; HILIC  blue). (E) PCA plot of 5-year-old samples for all protein purification methods (APFAR  red; DRP 
green; HILIC  blue). (F) PCA plot of 10-year-old samples for all protein purification methods (APFAR  red; DRP  green; HILIC  blue).
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FIGURE 8 | Gene Ontology annotation profiles for proteins identified from all block ages and protein purification methods. (A) GO profiles according to biological
processes. (B)GO profiles according to cellular components. The average proportions for all 17 patients per condition are shown with error bars indicating the standard
deviation. Blue bars refer to APFAR samples; Red bars refer to DRP samples; Green bars refer to HILIC samples. For all samples, 5-year-old samples are represented by
dots; 10-year-old samples are represented by diagonal lines.
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each of the plotted GO terms for biological processes, and
Figure 8B shows cellular components.
One-way ANOVA or Kruskal–Wallis tests were conducted
(results are listed in Supplementary Table S2) to determine if
there were any significant differences with regard to the %
frequency of occurrence of GO terms between block ages, as
well as for each protein purification method.
All GO terms (for all block ages and protein purification
methods) occurred at >15% frequency for all samples and are
clearly represented by Figure 8. Therefore all block ages and
protein purification methods used in this study demonstrate
more or less equivalent usability for proteomic analysis.
Statistically significant differences were mainly observed for 1-
year-old blocks processed via the APFAR and/or DRP methods.
Overall, the HILIC method showed least bias across all GO terms
plotted.
Statistical analyses for protein purification methods showed
that some GO terms for 1-year-old blocks processed via the
APFAR and DRP methods were significantly enriched (p < 0.05)
for % frequency of occurrence when using the APFAR method.
These GO terms were: catabolic process, cytoskeleton,
extracellular region, extracellular space, mitochondrion and
transport. The APFAR method differed significantly (depleted)
(p < 0.05) from both the DRP and HILIC methods for 1 and 5-
year-old blocks for % frequency of occurrence of the term “small
molecule metabolic process”.
Statistical analyses for the different block ages (processed via
the DRP method) showed that the 1-year-old blocks are
significantly enriched (p < 0.05) for GO terms
“mitochondrion” and “small molecule metabolic process”
when compared to the 5 and 10-year-old blocks. In addition,
for samples processed via the HILIC method, only the 10-year-
old blocks were significantly depleted (p < 0.05) for % frequency
of occurrence of the term “plasmamembrane” when compared to
the 1 and 5-year-old blocks. For samples processed via the
APFAR method, the 1-year-old blocks were significantly
enriched (p < 0.05) whereas the 10-year-old blocks were
significantly depleted (p < 0.05) with regard to the GO term
“cytoskeleton”.
Assessment of the Digestion Efficiency of
the Protein Purification Methods for all
Block Ages
To assess the reproducibility and digestion efficiency of the
different protein purification methods, the percentages of
missed cleavages across all samples were analyzed (shown
in Supplementary Image S4). To successfully analyze FFPE
tissues requires overcoming the issue of the formaldehyde
cross-linking between molecules [2, 4, 6, 11]. The most
important aspect to take into consideration for accurate
protein extraction from FFPE tissues is the cleavage of these
methylene bridges to allow for proper trypsin digestion. The
methylene bridges prevent trypsin from reaching its cleavage
sites. If the methylene bridges are not adequately cleaved, it
will result in improperly digested, cross-linked peptides that
will not produce correct MS results. Therefore, the effect of
storage time/block age on trypsin digestion efficiency was also
determined by comparing the percentage of missed cleavages
across all block ages.
Supplementary Image S4 shows that overall, all protein
purification methods and all block ages generated low
numbers of missed cleavages. The APFAR method
(Supplementary Image S4A) generated the lowest
percentages of missed cleavages with ≥85% of all peptides
for 1-year-old samples having no missed cleavages, and ≥90%
of all peptides for 5 and 10-year-old samples having no missed
cleavages. This was followed by the DRP method
(Supplementary Image S4B), with ≥85% of all peptides
(except for sample number DRP-9) for 1-year-old samples
having no missed cleavages, and ≥85% of all peptides for 5 and
10-year-old samples having no missed cleavages (except for
sample number DRP-34 of the 5-year-old cohort). The SP3/
HILIC method (Supplementary Image S4C) had overall
lower digestion efficiency with ≥80% of all peptides for 1
and 5-year-old samples having no missed cleavages, and ≥80%
of all peptides for 10-year-old samples having no missed
cleavages (except for samples HILIC-37 and HILIC-41).
The protein purification methods’ digestion efficiency
therefore does not appear to be only affected by the age of the
sample, since older and newer blocks gave varying results
depending on the processing method used [14]. found that
after deparaffinization and rehydration, cross-linked proteins
are efficiently digested with trypsin, without the need for
additional specialized reagents, even under mild conditions
typically used for fresh tissues. This is also observed here,
since all block ages and protein purification methods used
demonstrate sufficient trypsin activity/cleavage efficiency, with
all samples showing low levels of missed cleavages. Generally, the
percentage of missed cleavages of the present study was in the
range of several other recent reports [69–71], with lower
percentage of missed cleavages reported in [20].
Effects of Block Age and Protein
Purification Methods on Sample Proteome
Integrity
The oxidation of methionine is a major protein modification,
which converts methionine to methionine sulfoxide, and targets
the affected protein for degradation, both in vivo and in vitro [72].
Methionine oxidation is linked to processes relating to aging and
pathology (in vivo) as well as in vitro conditions caused by protein
purification, storage, light exposure, and exposure to free radicals
generated in the presence of metals during LC-MS/MS analysis
[72]. To determine the impact of long-term storage, the
percentage of peptides containing methionine oxidation (out
of the total number of peptides identified) was calculated for
all block ages and protein purification methods (Supplementary
Image S5).
Kruskal–Wallis tests were conducted to determine if the
percentage of peptides containing methionine oxidation were
significantly different between block ages for each protein
purification method (Supplementary Table S2). No significant
differences were found between 1, 5 and 10-year old blocks/
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samples processed via the APFAR [H (2)  1.23, p  0.54], DRP
[H (2)  0.86, p  0.65], or SP3/HILIC [H (2)  3.38, p  0.18]
methods. Supplementary Image S5 shows that for the 10-year-
old blocks/samples the percentage of peptides with methionine
oxidation are 8.77 ± 3.41%, 7.77 ± 2.41%, and 5.47 ± 2.13%, for
APFAR, DRP and SP3/HILIC respectively. Similar percentages of
peptides with methionine oxidation (7.65 ± 2.05% and 7.38 ±
2.15%) are observed for 1 and 5-year-old blocks/samples
processed via the APFAR method. The same is seen for 1 and
5-year-old blocks/samples processed via the DRP method (7.24 ±
2.11% and 6.83 ± 1.69%). The SP3/HILIC method has lower
percentages of peptides with methionine oxidation for all block
ages, with 4.34 ± 1.36%, 4.43 ± 1.16% and 5.47 ± 2.13%, for 1, 5,
and 10-year-old blocks/samples respectively. Therefore, the
choice of sample preparation/protein purification method may
contribute to methionine oxidation artifacts [72]. [73] found that
methionine oxidation increases during enzymatic digestion, with
the presence of residual metals in the digestion buffer, sample
contact with metal surfaces, as well as chromatography
separation.
The SP3/HILIC method’s results are in agreement with results
reported by [3] for newly preserved (<1-year-old) FFPE samples
(processed using acetone precipitation and sodium hydroxide
resolubilization for protein purification), which had methionine
oxidation ratios of 3.9–4.5% for all identified peptides. In contrast
[14], reported higher methionine oxidation levels and found that
archived colon adenoma tissues displayed an increase in
methionine oxidation with block age - from 16.8% after one
year of storage, 18.2% for 5-year-old samples up to 25.2% after
10 years of storage.
CONCLUSION
Archived FFPE tissue repositories are precious sources of clinical
material, often stored for decades, for clinical proteomic studies.
Since these preserved blocks may be conveniently stored at
ambient temperatures, it makes them easily accessible and cost
effective. However, standardized protocols for the proteomic
analysis of FFPE tissues have not been determined yet. In
addition, the effect of block age and storage at resource-
limited institutions, on protein quality remains unclear. We
have demonstrated, using recently developed protein
purification techniques (and FFPE human colorectal cancer
resection tissues) that, overall, block age mainly affects protein
yields during the protein extraction phase. Therefore, greater
amounts of starting material are required for older blocks prior to
LC-MS/MS analysis. Analyzed samples’ peptide and protein
identifications mainly differed according to the protein
purification method used and not block age, which mainly
impacted on tissue proteome composition.
This study is also of particular relevance, since it assessed the
performance of three different protein purification techniques on
tissues derived from samples stored over a long period of time
(1–10 years). The comparative analyses of these methods, across
different block ages, have not been carried out to our knowledge
and therefore this study provides both experimental data for this
assessment as well as statistical support. The different
methods show differences in the number of peptides and
proteins identified and sample proteome composition,
differences in reproducibility in terms of peptide
identification overlap, PCA variance, as well as protocol
digestion efficiency. Overall, the DRP and SP3/HILIC
methods performed the best, with the SP3/HILIC method
requiring less protein (and therefore less starting material)
than the other methods, therefore making it the most
sensitive and efficient protein purification method.
These results are encouraging since they indicate that long-
term storage of FFPE tissues does not significantly interfere with
retrospective proteomic analysis. In addition, variations in pre-
analytical factors (spanning a decade), such as tissue harvesting,
handling, the fixation protocol used as well as storage conditions
(at resource-limited institutions in developing countries), does
not affect protein extraction and shotgun proteomic analysis to a
significant extent.
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DRP detergent removal plates
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FDR False discovery rate
FFPE Formalin-fixed, paraffin-embedded
GO Gene ontology
H&E Hematoxylin and Eosin
HIAR Heat-induced antigen retrieval
HILIC Hydrophilic interaction liquid chromatography
LC Liquid chromatography




NSAF Normalized spectrum abundance factor
PCA Principal component analysis
PCC Pearson’s correlation coefficient
PSM Peptide Spectrum Match
PTM(s) Post-translational modification(s)
SDS Sodium dodecyl sulfate
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